hotspot -WSS

hotspot

author：hotspot 2025-09-06 02:11:09 - browse：4464

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

Readout LOUD podcast: Live from the 2023 STAT Summit

Roche drug slashes death risk in early

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Second xenotransplant done with gene

Results on Novartis prostate cancer therapy could expand its use

focus

hotspot

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Thermo Fisher plant for manufacturing gene therapies to expand

The high cost of giving birth even with insurance

How AI helped researchers track recovery from depression

Medical records are filled with copy

Results on Novartis prostate cancer therapy could expand its use

Supreme Court strikes down use of affirmative action

CDC's new outbreak response network to include Northeastern

Drug repurposing or repositioning? The language matters

Changes to biosimilar regulatory framework must prioritize patients

focus

Second xenotransplant done with gene

How Vertex's cystic fibrosis drug is changing patients' lives

FDA panel to weigh approval of NurOwn, controversial ALS drug

CDC's new outbreak response network to include Northeastern

STAT Summit: Ending the crisis of Black deaths in the U.S.

The problems with dementia villages

hotspot

hotspot

Wikipedia

focus